Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner
Journal of Psychoactive Drugs November 1, 2012 DOI: 10.1080/02791072.2012.736842 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Cross-sectional survey Peer reviewed |
|---|---|
| Sample size | 337 |
| Population | Adults recruited from the MAPS website and newsletter, most reporting use of various licit and illicit drugs including psychedelics |
| Topics | Cannabis LSD MDMA Mysticism Psilocybin Mystical experience |
| Keywords | Hallucinogen Context archaeology Recreational drug Recreational use Clinical psychology |
| Citations | 97 |
| Key findings | Use of LSD and psilocybin was significantly positively related to mystical experience scores in a dose-related manner, whereas use of MDMA, cannabis, cocaine, opiates, and alcohol was not. |
Abstract
Psychedelic drugs have long been known to be capable of inducing mystical or transcendental experiences. However, given the common "recreational" nature of much present-day psychedelic use, with typical doses tending to be lower than those commonly taken in the 1960s, the extent to which illicit use of psychedelics today is associated with mystical experiences is not known. Furthermore the mild psychedelic MDMA ("Ecstasy") is more popular today than "full" psychedelics such as LSD or psilocybin, and the contribution of illicit MDMA use to mystical experiences is not known. The present study recruited 337 adults from the website and newsletter of the Multidisciplinary Association for Psychedelic Studies (MAPS), most of whom reported use of a variety of drugs both licit and illicit including psychedelics. Although only a quarter of the sample reported "spiritual" motives for using psychedelics, use of LSD and psilocybin was significantly positively related to scores on two well-known indices of mystical experiences in a dose-related manner, whereas use of MDMA, cannabis, cocaine, opiates and alcohol was not. Results suggest that even in today's context of "recreational" drug use, psychedelics such as LSD and psilocybin, when taken at higher doses, continue to induce mystical experiences in many users.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
State of the evidence: Mysticism Supports
Use of LSD and psilocybin was significantly positively related to mystical experience scores in a dose-related manner, whereas use of MDMA, cannabis, cocaine, opiates, and alcohol was not.
Synthesized
Comparable studies
Other cross-sectional and survey studies on LSD, most cited first.
Citations in the library
Cited by 70
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI) Frontiers in Human Neuroscience June 14, 2016
- Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology March 1, 2015
- Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin Human Brain Mapping May 22, 2015
- Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates. Current Topics in Behavioral Neurosciences 2018
and 65 more in the library
Cites 6
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose?effect study Psychopharmacology March 1, 2004
- The Varieties of Religious Experience July 26, 2012
- LSD: My Problem Child The Antioch Review 1981
- Values and Beliefs of Psychedelic Drug Users: A Cross-Cultural Study Journal of Psychoactive Drugs June 1, 2006
and 1 more in the library